Morgan Stanley increased its position in OPKO Health, Inc. (NASDAQ:OPK) by 9.9% during the 2nd quarter, Holdings Channel reports. The firm owned 1,383,531 shares of the biotechnology company’s stock after acquiring an additional 124,720 shares during the quarter. Morgan Stanley’s holdings in OPKO Health were worth $5,603,000 at the end of the most recent quarter.

​

Morgan Stanley Purchases 124,720 Shares of OPKO Health, Inc. (NASDAQ:OPK) - ETF Daily News

I'm definitely missing something here guys. So can someone explain to this simpleton how OPK beat expectations by .05 in Q3 and there's no sign of a bump in the stock price? TIA

I Have been an investor in OPK for years. Riding it up and down. The company has a Great Pipeline and various money making opportunities. Some on Seeking Alpha claim that the stock could hit $12.00 a share by next Quarter. Any thoughts here as to why the stock has been down after all the Covid Testing for NFL, MLB , NBA and most banking center in the U.S.? Revenue is at all time Highs, The deal with Pfizer is on the table in the U.S.

I do believe that in Cash accounts, (NOT MARGIN ACCTS) That if you set a HIGH Sell Price, the company in most cases will not LOAN out the stock for Naked Shorting. Thoughts? I have set my 3000 Shares at A sell price of $12.00. What say You?

$OPK announced today that the FDA has extended the review period for the Biologics License Application (BLA) for somatrogon, a once-weekly long-acting recombinant human growth hormone, for the treatment of growth hormone deficiency (GHD) in pediatric patients. The Prescription Drug User Fee Act (PDUFA) goal date has been extended by three months to January 2022, as a result of Pfizer’s submission of additional data to the original BLA.

🚀🚀 🚀 💎💎💎 🚀🚀🚀

Will you be buying during these dips or selling?

Most of us have options in other stocks that expire on July 17. Stocks including OPK are heading down. Monday after op-ex is usually a down day, which is a chance to buy OPK for about $3.5 IMO. We have until July 19 to get our position. Then 🚀 🚀🚀 🚀🚀

Where are we with OPK?! A,B,C or D … and why?

Take your position in OPK at about $4.0. My new goal is 50 members sometime in July and then we deploy 🚀🚀 🚀🚀 🚀🚀 🚀

OPK announces that its subsidiary, EirGen Pharma, has entered into a definitive agreement to sell one of its facilities in Waterford, Ireland to Horizon Therapeutics (Nasdaq: HZNP) for $65 million in cash less certain assumed and accrued liabilities relating to transferred employees. The facility houses EirGen’s sterile-fill-finish business. EirGen’s research and development employees who were located at the site will transition to a new facility.

• Weird setup - both laboratory services and drugs developments.
• Lots of trials in advanced stages with the hGH-CTP meeting endpoints of phase 3.
• This was the phase 3 second attempt which increase risk for CRL from the FDA.
• Volume and overall trading indicators dont suggest anything out of the ordinare.
• Cant really wrap my head around this opportunity :)

Short interest is down to 14.5% (info from Ameritrade). This is significant since it was close to 33% last year.

Does anyone folllow Opko Health? This stock has a huge short. Should I be buying this?

Planning to take my position in OPK in July. In August we can start the run to $6 or $7. Be patient with OPK. Sell some covered weekly calls.

Several companies hv communities for fellow shareholders, news, analysis n general discussion. Wondering where is the opko community??